Vimarsana
Biggest News Aggregation in the World

Page 38 - Multiple System Atrophy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple System Atrophy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple System Atrophy Today - Breaking & Trending Today

Alterity Therapeutics Announces Presentation of Wearable Sensor Data from the bioMUSE Natural History Study at the International Congress of Parkinson's Disease - Vimarsana News

Alterity Therapeutics Announces Presentation of Wearable Sensor Data from the bioMUSE Natural History Study at the International Congress of Parkinson's Disease

– Wearable sensors strongly correlated with clinical scales on motor impairment – – bioMUSE Study Validates Use of Wearable Sensors...

Inhibikase Therapeutics to Present at the Grand Challenges in Parkinson's Disease Conference - Vimarsana News

Inhibikase Therapeutics to Present at the Grand Challenges in Parkinson's Disease Conference

/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing protein kinase inhibitor...

Inhibikase Therapeutics to Present at the Grand Challenges in Parkinson's Disease Conference - Vimarsana News

Inhibikase Therapeutics to Present at the Grand Challenges in Parkinson's Disease Conference

/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing protein kinase inhibitor...

Inhibikase Therapeutics to Present at the Grand Challenges in Parkinson's Disease Conference - Vimarsana News

Inhibikase Therapeutics to Present at the Grand Challenges in Parkinson's Disease Conference

BOSTON and ATLANTA, Sept. 21, 2022 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical compa...

Inhibikase Therapeutics to Present at the Grand Challenges in Parkinson's Disease Conference - Vimarsana News

Inhibikase Therapeutics to Present at the Grand Challenges in Parkinson's Disease Conference

BOSTON and ATLANTA, Sept. 21, 2022 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson'...